Abstracts

Filters

Clear Filters

Monday, September 29

10:55 AM - 11:05 AM PT

205 - Anlotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in Patients Diagnosed with Small Cell Lung Cancer: A Single-Arm, Phase 2 Trial

Speaker: Deng, Lei - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
10:55 AM - 11:05 AM PT

217 - Lack of Adoption of the Standard Radiation Therapy Prescription

Speaker: Dance, Michael, MS - University of North Carolina at Chapel Hill, Chapel Hill, NC
10:55 AM - 11:05 AM PT
11:05 AM - 11:15 AM PT

206 - Durable Survival and Updated Safety of TQB2450 plus Anlotinib Maintenance Therapy in Limited-Stage Small Cell Lung Cancer: Extended Follow-Up from a Prospective Phase Ib Trial

Speaker: Meng, Xiangjiao - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan